Who is sponsoring NCT04859738?

NCT04859738 is sponsored by TC Erciyes University.

What drugs are being tested in NCT04859738?

Interventions in NCT04859738: Lidocaine Spray, Benzokain Sprey, Alcohol.

What condition does NCT04859738 study?

NCT04859738 studies Peripheral Intravenous Catheterization Application.

Is NCT04859738 still recruiting?

NCT04859738 is currently completed. Last updated 26 April 2021.

Last reviewed 2021-04-26 · How we verify

NCT04859738

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Lidocaine and Benzocaine on Pain and Injection Satisfaction in Peripheral Intravenous Catheter Application

Completed Phase 3 Last updated 26 April 2021

What this trial tests

Phase 3 trial testing Lidocaine Spray in Peripheral Intravenous Catheterization Application in 120 participants. Completed in 20 October 2020.

Timeline

4 March 2020

Primary endpoint
7 July 2020

20 October 2020

Quick facts

Lead sponsor	TC Erciyes University
Phase	Phase 3
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	factorial
Masking	single
Primary purpose	prevention
Enrollment	120
Start date	4 March 2020
Primary completion	7 July 2020
Estimated completion	20 October 2020
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Lidocaine Spray — full drug profile →
Benzokain Sprey — full drug profile →
Alcohol — full drug profile →

Conditions studied

Peripheral Intravenous Catheterization Application — all drugs for Peripheral Intravenous Catheterization Application →

Sponsor

TC Erciyes University

Who can join

Adults 18 to 65, any sex, with Peripheral Intravenous Catheterization Application. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objective: This research was conducted as a randomized controlled, double-blind experimental study to determine the effect of topical lidocaine and benzocaine on patient's pain and injection satisfaction before peripheral intravenous catheter application. Study Design: The study was completed with 120 individuals who were treated in the green area of a University Hospital Emergency Service and met the inclusion criteria of the study. In collecting research data; Case Report Form (ORF), Baseline Algometer (66 Lb / 30 Kg) and Informed Consent Form were used. Lidocaine Spray, Benzocaine Spray and Alcohol were used in research groups.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Comparison of Two Topical Pharmacological Agents in Alleviating Peripheral Intravenous Catheterization Induced Pain in Adults: A Randomized Controlled Study.
Kaplan A, Bayat M, Çinar SL, Yerer MB, et al · · 2024 · PMID 41256962 · DOI 10.14744/cpr.2024.15497

Verify or expand the search:

Other trials of Lidocaine Spray

Trials testing the same drug.

NCT06185933 — Lidocaine Spray vs Viscous Lidocaine Solution Plus Lidocaine Spray in Patients Undergoing Non-Sedated EGD · NA · enrolling by invitation

Other TC Erciyes University trials

Trials by the same sponsor.

NCT07007858 — Effects of High-Velocity Passive Stretch on Spasticity, Function, and Muscle Structure in Spastic CP Children · NA · enrolling by invitation
NCT07529964 — MMP-2/3 and Periapical Healing Outcomes · not yet recruiting
NCT07526831 — Comparison of the Analgesic Efficacy of Adductor Canal Block and Combined Adductor Canal Block Plus IPACK Block in Knee · recruiting
NCT07371806 — EFFETCS OF MİNDFULNESS-BASED STRESS REDUCTION İN WOMEN WİTH CORONARY ARTERY DİSEASE · NA · not yet recruiting
NCT07499947 — Predicting Spinal Hypotension in Cesarean Section · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04859738 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by TC Erciyes University
Last refreshed: 26 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04859738.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing